首页 > 最新文献

Clinical case reports and reviews最新文献

英文 中文
Study of new energy-based noninvasive therapies for nonalcoholic fatty liver disease 基于能量的非酒精性脂肪肝无创治疗新方法的研究
Pub Date : 2021-01-01 DOI: 10.15761/CCRR.1000500
Miachon, Chavantes Mc
The incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic hepatic steatosis (NAH) remain unknown. It is estimated that 20 to 40% of the Western population is affected by NAFLD. NAFLD is the most common form of chronic liver disease in the world, with an estimated prevalence of approximately 30% in the US. Most cases occur in people aged between 40 and 60 years, but NAFLD is becoming increasingly prevalent in the pediatric population [1]. Although initially it was considered a disease that predominantly affects the female sex, it is currently understood that both sexes are affected equally. It is believed that the prevalence in Hispanics is higher than in whites, while on the other hand, African Americans are less susceptible to the progressive form of the disease and the Asian and Pacific regions are less affected [2]. It is expected to become the main indication for liver transplantation in the future, replacing hepatitis C.
非酒精性脂肪性肝病(NAFLD)和非酒精性肝脂肪变性(NAH)的发病率和患病率尚不清楚。据估计,20%到40%的西方人口受到NAFLD的影响。NAFLD是世界上最常见的慢性肝病,在美国估计患病率约为30%。大多数病例发生在40至60岁的人群中,但NAFLD在儿科人群中越来越普遍。虽然最初认为这是一种主要影响女性的疾病,但目前人们了解到两性都同样受到影响。据信,西班牙裔美国人的患病率高于白人,而另一方面,非洲裔美国人不易患这种疾病的进行性形式,亚洲和太平洋地区的发病率较低。它有望在未来取代丙型肝炎成为肝移植的主要适应症。
{"title":"Study of new energy-based noninvasive therapies for nonalcoholic fatty liver disease","authors":"Miachon, Chavantes Mc","doi":"10.15761/CCRR.1000500","DOIUrl":"https://doi.org/10.15761/CCRR.1000500","url":null,"abstract":"The incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic hepatic steatosis (NAH) remain unknown. It is estimated that 20 to 40% of the Western population is affected by NAFLD. NAFLD is the most common form of chronic liver disease in the world, with an estimated prevalence of approximately 30% in the US. Most cases occur in people aged between 40 and 60 years, but NAFLD is becoming increasingly prevalent in the pediatric population [1]. Although initially it was considered a disease that predominantly affects the female sex, it is currently understood that both sexes are affected equally. It is believed that the prevalence in Hispanics is higher than in whites, while on the other hand, African Americans are less susceptible to the progressive form of the disease and the Asian and Pacific regions are less affected [2]. It is expected to become the main indication for liver transplantation in the future, replacing hepatitis C.","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of biosimilars in rheumatoid arthritis - Process from R & D to marketing and trends in the world 生物类似药在类风湿关节炎中的作用——从研发到销售的过程和世界趋势
Pub Date : 2021-01-01 DOI: 10.15761/ccrr.1000509
H. Matsuno
Figures 1 and 2 shows the trend of the sale of advanced therapeutic drugs for rheumatoid arthritis (RA) currently available commercially in Japan. After the release of infliximab in 2003, biological products were introduced to the market with great frequency, and biological products with different mechanisms of action and dosing regimens became available (the use of rituximab for RA is not approved in Japan, unlike in overseas countries). Ten years after the release of the first biological product in Japan, the sale of Janus kinase inhibitors was promoted, and biosimilars (BSs) were also actively marketed.
图1和图2显示了目前在日本上市的用于类风湿性关节炎(RA)的先进治疗药物的销售趋势。2003年英夫利昔单抗上市后,生物制品大量进入市场,出现了不同作用机制和给药方案的生物制品(与国外不同,日本未批准使用美罗华治疗RA)。第一个生物制品在日本上市10年后,Janus激酶抑制剂的销售得到了促进,生物仿制药(BSs)也积极上市。
{"title":"Role of biosimilars in rheumatoid arthritis - Process from R & D to marketing and trends in the world","authors":"H. Matsuno","doi":"10.15761/ccrr.1000509","DOIUrl":"https://doi.org/10.15761/ccrr.1000509","url":null,"abstract":"Figures 1 and 2 shows the trend of the sale of advanced therapeutic drugs for rheumatoid arthritis (RA) currently available commercially in Japan. After the release of infliximab in 2003, biological products were introduced to the market with great frequency, and biological products with different mechanisms of action and dosing regimens became available (the use of rituximab for RA is not approved in Japan, unlike in overseas countries). Ten years after the release of the first biological product in Japan, the sale of Janus kinase inhibitors was promoted, and biosimilars (BSs) were also actively marketed.","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progressive cavitational leukoencephalopathy: An enigma 进行性空泡性脑白质病:一个谜
Pub Date : 2021-01-01 DOI: 10.15761/CCRR.1000497
García Divahia, Martínez-Lizaga Natalia, Lanau Sara, Espinosa Eugenia
from rapidly progressive deterioration to long periods of clinical stability; in newborns it causes severe neurological and systemic alterations, including seizures, hypotonia, growth retardation, lactic acidosis and respiratory failure [4]. Given the non-specific neurological symptoms and neuroimaging features, a differential diagnosis with infections or immunological conditions that involve the CNS is essential, an important finding Abstract Introduction: Progressive cavitational leukoencephalopathy (PCL) is a recently described pathology, with few cases reported in the world literature. It is characterized by progressive neurological deterioration and characteristic neuroimaging findings, which distinguish this disorder as a unique entity given the massive cystic degeneration . Patients and methods: A case of a female infant with regression of motor skills and speech is described at 27 months, followed by progressive neurological deterioration during the following year. Results: In cranial MR findings, white matter compromise and cystic degeneration with contrast enhancement were observed, along with a brain MRS with double negative lactate spikes. Enzymatic study of leukodystrophies, genetic panel for leukodystrophies, and negative mitochondrial exome. Conclusions: Due to the progressive form of the disease and paraclinical criteria, it is concluded that the patient meets the diagnostic criteria for PCL. This entity does not have treatment; only supportive care is available. The prognosis is fatal, with an average life of up to 14 years in the case studies described.
从快速进行性恶化到长期临床稳定;在新生儿中,它会引起严重的神经系统和全身改变,包括癫痫发作、张力低下、生长迟缓、乳酸性酸中毒和呼吸衰竭。鉴于非特异性神经症状和神经影像学特征,与涉及中枢神经系统的感染或免疫状况的鉴别诊断是必不可少的,这是一项重要发现。摘要简介:进行性空化性白质脑病(PCL)是一种最近被描述的病理,在世界文献中报道的病例很少。它的特点是进行性神经退化和特征性的神经影像学发现,这区分了这种疾病作为一个独特的实体给予巨大的囊性变性。患者和方法:本文报告1例女性婴儿在27个月时出现运动技能和语言退化,随后在接下来的一年中出现进行性神经退化。结果:在颅MR检查中,观察到白质妥协和囊性变性,对比度增强,同时脑MR显示双阴性乳酸峰。脑白质营养不良的酶学研究,脑白质营养不良的遗传面板,和负线粒体外显子组。结论:由于本病呈进行性发展,符合临床诊断标准,符合PCL诊断标准。这个实体没有治疗;只有支持性护理可用。预后是致命的,在上述案例研究中,平均寿命可达14年。
{"title":"Progressive cavitational leukoencephalopathy: An enigma","authors":"García Divahia, Martínez-Lizaga Natalia, Lanau Sara, Espinosa Eugenia","doi":"10.15761/CCRR.1000497","DOIUrl":"https://doi.org/10.15761/CCRR.1000497","url":null,"abstract":"from rapidly progressive deterioration to long periods of clinical stability; in newborns it causes severe neurological and systemic alterations, including seizures, hypotonia, growth retardation, lactic acidosis and respiratory failure [4]. Given the non-specific neurological symptoms and neuroimaging features, a differential diagnosis with infections or immunological conditions that involve the CNS is essential, an important finding Abstract Introduction: Progressive cavitational leukoencephalopathy (PCL) is a recently described pathology, with few cases reported in the world literature. It is characterized by progressive neurological deterioration and characteristic neuroimaging findings, which distinguish this disorder as a unique entity given the massive cystic degeneration . Patients and methods: A case of a female infant with regression of motor skills and speech is described at 27 months, followed by progressive neurological deterioration during the following year. Results: In cranial MR findings, white matter compromise and cystic degeneration with contrast enhancement were observed, along with a brain MRS with double negative lactate spikes. Enzymatic study of leukodystrophies, genetic panel for leukodystrophies, and negative mitochondrial exome. Conclusions: Due to the progressive form of the disease and paraclinical criteria, it is concluded that the patient meets the diagnostic criteria for PCL. This entity does not have treatment; only supportive care is available. The prognosis is fatal, with an average life of up to 14 years in the case studies described.","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67448885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Infant with Sandhoff disease: A case report 婴儿桑德霍夫病1例
Pub Date : 2021-01-01 DOI: 10.15761/ccrr.1000506
Z. Sabzi, N. Abkari, Seraj aldin Arefnia
{"title":"An Infant with Sandhoff disease: A case report","authors":"Z. Sabzi, N. Abkari, Seraj aldin Arefnia","doi":"10.15761/ccrr.1000506","DOIUrl":"https://doi.org/10.15761/ccrr.1000506","url":null,"abstract":"","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enterocolitis with fulminate sepsis in a newborn with tricho-hepato-enteric syndrome: A case report 新生儿肠结肠炎伴暴发性败血症合并tricho-肝-肠综合征1例报告
Pub Date : 2021-01-01 DOI: 10.15761/CCRR.1000498
D. Lorant, K. Kua
Tricho-hepato-enteric syndrome is a rare autosomal recessive enteropathy that first presents as intractable diarrhea in neonates. Diarrhea persists throughout life and patients are dependent on parenteral nutrition for growth. Additional features include facial dysmorphism, trichorrhexis nodosa (woolly hair), intra-uterine growth restriction, hepatic disease, skin anomalies and a depressed immune system. Tricho-hepato-enteric syndrome is a life limiting disease with variability in its manifestations and severity. Mutations in two different genes, TTC37 or SKIV2L , cause the disorder. In this case report we present a neonate with a novel mutation in TTC37 that resulted in a severe phenotype associated with fulminate sepsis. The infant presented at one week of age with sudden onset of diarrhea and dehydration. Tricho-hepato-enteric syndrome was diagnosed by whole exome sequencing but was not initially considered because the infant lacked many of the diagnostic clinical features. Soon after presentation, the infant developed pneumoperitoneum and necrosis of entire bowel. The blood culture was positive for Clostridium perfringens. Autopsy showed bacteria in the parenchyma and vasculature of all major internal organs as well as within the bone marrow, connective tissue and skeletal muscle but there was minimal inflammatory response. The lack of migration of white blood cells to the sites of infection is likely due to the combined immunodeficiency reported in patients with tricho-hepato-enteric
三联肝肠综合征是一种罕见的常染色体隐性肠病,首先表现为新生儿难治性腹泻。腹泻持续一生,患者依赖肠外营养生长。其他特征包括面部畸形、结节性毛癣(羊毛状毛发)、子宫内生长受限、肝病、皮肤异常和免疫系统低下。肝肠综合征是一种限制生命的疾病,其表现和严重程度各不相同。两种不同基因TTC37或SKIV2L的突变导致了这种疾病。在这个病例报告中,我们提出了一个新的TTC37突变的新生儿,导致严重的表型与暴雷性败血症相关。婴儿在1周龄时出现突发性腹泻和脱水。tricho -肝肠综合征是通过全外显子组测序诊断出来的,但由于婴儿缺乏许多诊断性临床特征,最初并未考虑。发病后不久,婴儿出现气腹和全肠坏死。血培养产气荚膜梭菌阳性。尸检显示,所有主要内脏器官的薄壁组织和脉管系统以及骨髓、结缔组织和骨骼肌中都有细菌,但炎症反应很小。白细胞缺乏迁移到感染部位可能是由于在tricho-hepato-enteric患者中报道的联合免疫缺陷
{"title":"Enterocolitis with fulminate sepsis in a newborn with tricho-hepato-enteric syndrome: A case report","authors":"D. Lorant, K. Kua","doi":"10.15761/CCRR.1000498","DOIUrl":"https://doi.org/10.15761/CCRR.1000498","url":null,"abstract":"Tricho-hepato-enteric syndrome is a rare autosomal recessive enteropathy that first presents as intractable diarrhea in neonates. Diarrhea persists throughout life and patients are dependent on parenteral nutrition for growth. Additional features include facial dysmorphism, trichorrhexis nodosa (woolly hair), intra-uterine growth restriction, hepatic disease, skin anomalies and a depressed immune system. Tricho-hepato-enteric syndrome is a life limiting disease with variability in its manifestations and severity. Mutations in two different genes, TTC37 or SKIV2L , cause the disorder. In this case report we present a neonate with a novel mutation in TTC37 that resulted in a severe phenotype associated with fulminate sepsis. The infant presented at one week of age with sudden onset of diarrhea and dehydration. Tricho-hepato-enteric syndrome was diagnosed by whole exome sequencing but was not initially considered because the infant lacked many of the diagnostic clinical features. Soon after presentation, the infant developed pneumoperitoneum and necrosis of entire bowel. The blood culture was positive for Clostridium perfringens. Autopsy showed bacteria in the parenchyma and vasculature of all major internal organs as well as within the bone marrow, connective tissue and skeletal muscle but there was minimal inflammatory response. The lack of migration of white blood cells to the sites of infection is likely due to the combined immunodeficiency reported in patients with tricho-hepato-enteric","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers in early colorectal, esophageal, and gastric cancer 早期结直肠癌、食管癌和胃癌的生物标志物
Pub Date : 2021-01-01 DOI: 10.15761/ccrr.1000508
P. García-Alfonso, G. T. Pérez-Solero, J. Soto Alsar, A. M. Muñoz Martín, J. Parrondo
{"title":"Biomarkers in early colorectal, esophageal, and gastric cancer","authors":"P. García-Alfonso, G. T. Pérez-Solero, J. Soto Alsar, A. M. Muñoz Martín, J. Parrondo","doi":"10.15761/ccrr.1000508","DOIUrl":"https://doi.org/10.15761/ccrr.1000508","url":null,"abstract":"","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An antioxidant approach directed to non-healing wounds activation - A case report study 一种针对未愈合伤口激活的抗氧化剂方法-一个病例报告研究
Pub Date : 2021-01-01 DOI: 10.15761/CCRR.1000499
J. F. Jiménez-García, G. Aguilera-Manrique, Laura Parra-Anguita, J. Torra-Bou, Irene Villegas-Tripiana, F. P. García-Fernández
It is well known that oxidative stress is a pathologic condition that compromises wound evolution, contributing to inflammatory environment maintaining and wound healing stagnation. This condition specially affects to aged people and to patients with important comorbidities, whereby healing capabilities are significantly impaired. In this work, a new therapeutic approach through a new antioxidant technology with natural components has been applied, in order to manage the oxidative stress, in 31 patients with complex chronic wounds of different etiologies, attended to the Sanitary West District in Almería (Spain). Wound assessments were performed at 4, 8 and 12 weeks and main endpoints included the evolution of wound healing (% of healing rate and Resvech 2.0 score) and pain relief. The treatment with antioxidant dressing produced a significant decrease of RESVECH 2.0 of 37.28%, 58.52% and 67.8% at 4, 8 and 12 weeks respectively and during the 12 week follow-up, 16/31 wounds totally healed (50%). In addition, a decrease in pain and biofilm presence in wounds were observed. In conclusion, the analyzed antioxidant approach could be a new therapeutic strategy directed to overcome the inflammatory phase in complex wounds and allow the progression over the healing process.
众所周知,氧化应激是一种损害伤口进化的病理状态,有助于炎症环境的维持和伤口愈合的停滞。这种情况特别影响老年人和有重要合并症的患者,因此愈合能力明显受损。在这项工作中,一种新的治疗方法通过一种新的抗氧化技术与天然成分已被应用,以管理氧化应激,在31例不同病因的复杂慢性伤口患者,参加了卫生西区Almería(西班牙)。在第4、8和12周进行伤口评估,主要终点包括伤口愈合的进展(愈合率百分比和Resvech 2.0评分)和疼痛缓解。抗氧化敷料治疗后第4周、8周和12周RESVECH 2.0分别下降37.28%、58.52%和67.8%,随访12周,16/31创面完全愈合(50%)。此外,还观察到伤口疼痛和生物膜的减少。总之,所分析的抗氧化方法可能是一种新的治疗策略,旨在克服复杂伤口的炎症阶段,并允许愈合过程的进展。
{"title":"An antioxidant approach directed to non-healing wounds activation - A case report study","authors":"J. F. Jiménez-García, G. Aguilera-Manrique, Laura Parra-Anguita, J. Torra-Bou, Irene Villegas-Tripiana, F. P. García-Fernández","doi":"10.15761/CCRR.1000499","DOIUrl":"https://doi.org/10.15761/CCRR.1000499","url":null,"abstract":"It is well known that oxidative stress is a pathologic condition that compromises wound evolution, contributing to inflammatory environment maintaining and wound healing stagnation. This condition specially affects to aged people and to patients with important comorbidities, whereby healing capabilities are significantly impaired. In this work, a new therapeutic approach through a new antioxidant technology with natural components has been applied, in order to manage the oxidative stress, in 31 patients with complex chronic wounds of different etiologies, attended to the Sanitary West District in Almería (Spain). Wound assessments were performed at 4, 8 and 12 weeks and main endpoints included the evolution of wound healing (% of healing rate and Resvech 2.0 score) and pain relief. The treatment with antioxidant dressing produced a significant decrease of RESVECH 2.0 of 37.28%, 58.52% and 67.8% at 4, 8 and 12 weeks respectively and during the 12 week follow-up, 16/31 wounds totally healed (50%). In addition, a decrease in pain and biofilm presence in wounds were observed. In conclusion, the analyzed antioxidant approach could be a new therapeutic strategy directed to overcome the inflammatory phase in complex wounds and allow the progression over the healing process.","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Gastrointestinal symptom and stress recall survey in frontline healthcare workers after consumption of a combined quebracho/conker tree/M. balsamea willd extract during the COVID-19 pandemic 一线医护人员食用桂树/椰子树/枇杷膏后胃肠道症状及应激回忆调查在COVID-19大流行期间,凤仙花将提取
Pub Date : 2021-01-01 DOI: 10.15761/CCRR.1000502
K. Brown, Brandi Scott-Hoy, B. Burnett
Since the coronavirus (SARS-CoV-2) pandemic began, frontline workers in general face the stress of uncertainty and fear in encountering infected individuals in the wider public. Frontline healthcare workers are at particular risk for increasing stress levels when treating and caring for COVID-19 patients. These healthcare professionals experience anxiety, psychological pressure and post-traumatic stress with their associated workloads [1-3]. Post-traumatic stress accompanying the COVID-19 outbreak in healthcare workers also elicits hyperarousal and decreased sleep quality [4]. Post-traumatic stress is known to induce somatization with gastrointestinal (GI) symptoms [5].
自冠状病毒(SARS-CoV-2)大流行开始以来,一线工作人员普遍面临着在更广泛的公众中遇到感染者的不确定性和恐惧的压力。一线医护人员在治疗和护理COVID-19患者时面临的压力水平增加的风险尤其大。这些医疗保健专业人员在相关的工作量中经历焦虑、心理压力和创伤后应激[1-3]。在医护人员中,伴随COVID-19爆发的创伤后应激也会导致过度觉醒和睡眠质量下降。创伤后应激可诱发躯体化并伴有胃肠道症状[5]。
{"title":"Gastrointestinal symptom and stress recall survey in frontline healthcare workers after consumption of a combined quebracho/conker tree/M. balsamea willd extract during the COVID-19 pandemic","authors":"K. Brown, Brandi Scott-Hoy, B. Burnett","doi":"10.15761/CCRR.1000502","DOIUrl":"https://doi.org/10.15761/CCRR.1000502","url":null,"abstract":"Since the coronavirus (SARS-CoV-2) pandemic began, frontline workers in general face the stress of uncertainty and fear in encountering infected individuals in the wider public. Frontline healthcare workers are at particular risk for increasing stress levels when treating and caring for COVID-19 patients. These healthcare professionals experience anxiety, psychological pressure and post-traumatic stress with their associated workloads [1-3]. Post-traumatic stress accompanying the COVID-19 outbreak in healthcare workers also elicits hyperarousal and decreased sleep quality [4]. Post-traumatic stress is known to induce somatization with gastrointestinal (GI) symptoms [5].","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare cause of agranulocytosis 粒细胞缺乏症的罕见病因
Pub Date : 2021-01-01 DOI: 10.15761/CCRR.1000501
H. Luís, C. Barros, M. Fernandes, S. Granito
she Abstract Clozapine, an atypical antipsychotic agent, is useful in the treatment of patients with psychotic symptoms. However, severe adverse effects, such as agranulocytosis, can restrict its indications. We present a case of a 42-year-old Caucasian woman with a 4-year history of persistent delusion disorder, who presented with fatigue and fever and was ultimately diagnosed with agranulocytosis due to clozapine. Clozapine-induced agranulocytosis is an uncommon condition, but potentially fatal in consequences. Each patient with an episode of agranulocytosis should be assessed individually, with special attention to risk factors. Upon that, the decision about clozapine rechallenge or withdrawal should be made.
氯氮平是一种非典型抗精神病药物,可用于治疗有精神病症状的患者。然而,严重的不良反应,如粒细胞缺乏症,可以限制其适应症。我们报告一例42岁的白人女性,有4年的持续性妄想障碍病史,她表现为疲劳和发烧,最终被诊断为氯氮平引起的粒细胞缺乏症。氯氮平引起的粒细胞缺乏症是一种罕见的疾病,但其后果可能致命。每个有粒细胞缺乏症发作的患者应单独评估,特别注意危险因素。在此基础上,应决定是否重新使用氯氮平或停药。
{"title":"A rare cause of agranulocytosis","authors":"H. Luís, C. Barros, M. Fernandes, S. Granito","doi":"10.15761/CCRR.1000501","DOIUrl":"https://doi.org/10.15761/CCRR.1000501","url":null,"abstract":"she Abstract Clozapine, an atypical antipsychotic agent, is useful in the treatment of patients with psychotic symptoms. However, severe adverse effects, such as agranulocytosis, can restrict its indications. We present a case of a 42-year-old Caucasian woman with a 4-year history of persistent delusion disorder, who presented with fatigue and fever and was ultimately diagnosed with agranulocytosis due to clozapine. Clozapine-induced agranulocytosis is an uncommon condition, but potentially fatal in consequences. Each patient with an episode of agranulocytosis should be assessed individually, with special attention to risk factors. Upon that, the decision about clozapine rechallenge or withdrawal should be made.","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of knotted ureteral stent: A case report and comprehensive review of literature 输尿管支架打结的处理:1例报告及文献综合复习
Pub Date : 2021-01-01 DOI: 10.15761/ccrr.1000507
Z. Choo, Seok Kwan Felicia Hong, Yee Mun Lee
{"title":"Management of knotted ureteral stent: A case report and comprehensive review of literature","authors":"Z. Choo, Seok Kwan Felicia Hong, Yee Mun Lee","doi":"10.15761/ccrr.1000507","DOIUrl":"https://doi.org/10.15761/ccrr.1000507","url":null,"abstract":"","PeriodicalId":72607,"journal":{"name":"Clinical case reports and reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67449543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Clinical case reports and reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1